Acute Coronary Syndrome

A study presented at TCT 2018 questioned the benefits of “drip-and-ship” for elderly patients with ST-segment elevation myocardial infarction (STEMI), finding patients in their 80s or older who were transferred with fibrinolytic therapy for PCI had an eight-fold risk of hemorrhagic stroke but no survival advantage.

Fewer than one-third of Chinese patients with acute coronary syndromes (ACS) receive guidance to participate in cardiac rehabilitation, according to research presented Oct. 11 at the Great Wall International Congress of Cardiology.

People with unrecognized myocardial infarction carry a lower short-term risk of death but an equal 10-year risk of mortality compared to those with clinically diagnosed heart attacks, according to an analysis of the ICELAND MI study published in JAMA Cardiology.

For the first time, the World Health Organization (WHO) has included ambient noise from leisure-time activities in its guidelines on how cumulative exposure to high volumes can lead to health problems, including stress, hypertension and heart disease.

A genomic risk prediction tool developed by researchers in Australia and the U.K. has achieved greater risk discrimination than its predecessors while identifying patients at the highest and lowest likelihood of developing coronary artery disease (CAD), according to a study published ahead of print in the Journal of the American College of Cardiology.

A machine learning tool developed by researchers at Michigan State University can accurately predict an individual’s height within an inch and may offer more precise CVD and cancer risk assessment in the future, according to a report featured this month in Genetics.

Fractional flow reserve (FFR) can be closely approximated using conventional coronary angiography and propriety software, according to the FAST-FFR study published online in Circulation. The findings offer a potential route for more patients with suspected coronary artery disease to receive functional assessment of lesions without the need for a guidewire or hyperemic agents.

The Hospital Readmissions Reduction Program (HRRP) has successfully slashed readmissions for heart failure, acute MI (AMI) and pneumonia without causing mortality increases, according to an analysis of Medicare data published in JAMA Network Open. But the author of an accompanying editorial isn’t convinced the results are so positive.

In patients with atrial fibrillation who have experienced MI or undergone percutaneous coronary intervention (PCI), treatment with a combination of direct oral anticoagulants (DOACs) and dual antiplatelet therapy (DAPT) could significantly decrease the risk of bleeding and other major thromboembolic events, according to research published ahead of print in the Journal of the American College of Cardiology.

Cardiovascular risk factors have similar effects on the incidence of coronary heart disease (CHD) and ischemic stroke in women, researchers report in the first large-scale study of its kind in female patients.

Abbott has received a CE mark for its High Sensitive Troponin-I test—a diagnostic test designed to predict heart disease even in patients without cardiac symptoms—the company announced this week.

Though they might provide some benefit to high-risk patients in the month after a heart attack, wearable cardioverter-defibrillators don’t significantly lower the rate of arrhythmic death in those who have suffered myocardial infarctions, according to work published in the New England Journal of Medicine Sept. 27.